https://adisinsight.springer.com/drugs/800052582?error=cookies_not_supported&code=08017085-3ebf-42b9-bc97-55949dc9c4ea
Mirzotamab clezutoclax - AbbVie - AdisInsight
Mirzotamab clezutoclax (also known as ABBV 155) is an antibody drug conjugate (ADC), being developed by AbbVie for the treatment of advanced solid tumours and
abbvieadisinsight